McCue C, Lee WH, Vandereydt B, et al. Alternating Electrochemical Redox-Cycling on Nanocomposite Biointerface for High-Efficiency Enzyme-Free Cell Detachment. ACS nano. 2025. doi:10.1021/acsnano.5c09950
Publications
Prapiadou S, Langefeld CD, Sekar P, et al. Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case-Control Study. Annals of clinical and translational neurology. 2025. doi:10.1002/acn3.70230
Fan B, Dennis E, Mehta NH, et al. Somatic Mutation Identified in a Patient with Calvarial Venous Malformations. Genes. 2025;16(10). doi:10.3390/genes16101123
Yoo YC, Lin L, Lee S, Shin YR, Oh JE, Kim NY. Palonosetron, a 5-HT3 Receptor Antagonist, Induces G1 Cell Cycle Arrest and Autophagy in Gastric Cancer Cells. International journal of molecular sciences. 2025;26(20). doi:10.3390/ijms262010039
Mboowa G. Reimagining Tuberculosis Control in the Era of Genomics: The Case for Global Investment in Genomic Surveillance. Pathogens (Basel, Switzerland). 2025;14(10). doi:10.3390/pathogens14100975
Martins F, André R, Planet E, et al. The ’mono-side’ of cutaneous adverse drug reactions. Journal of the European Academy of Dermatology and Venereology : JEADV. 2025. doi:10.1111/jdv.70128
Carver S, Taraszka K, Groha S, Gusev A. Discovery of disease-associated cellular states using ResidPCA in single-cell RNA and ATAC sequencing data. HGG advances. 2025:100538. doi:10.1016/j.xhgg.2025.100538
Zimerman A, Kamanu FK, Melloni GEM, et al. Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic Disease. European journal of preventive cardiology. 2025. doi:10.1093/eurjpc/zwaf693
Butt H, Sathish S, London E, et al. Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model. Blood advances. 2025. doi:10.1182/bloodadvances.2025017321
Tesfai K, DÃaz LA, Arab JP, et al. Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Alimentary pharmacology & therapeutics. 2025. doi:10.1111/apt.70433